Published in Obes Facts on February 16, 2011
The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron (2003) 6.05
Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Clin Chem (2006) 2.20
Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes (2010) 2.01
Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology (2004) 1.70
Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets. Am J Physiol Endocrinol Metab (2013) 1.54
The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry. Dtsch Arztebl Int (2009) 1.46
Genetic determinants of serum testosterone concentrations in men. PLoS Genet (2011) 1.45
A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation. PLoS Genet (2012) 1.23
High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. J Clin Endocrinol Metab (2009) 1.17
Adrenal venous sampling: evaluation of the German Conn's registry. Hypertension (2011) 1.15
A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3. Hum Mol Genet (2011) 1.10
Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations. J Clin Endocrinol Metab (2014) 1.09
Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab (2008) 1.08
Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans. J Clin Endocrinol Metab (2013) 1.08
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance. Eur J Endocrinol (2006) 1.05
Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats. Endocrinology (2013) 1.05
Observational study mortality in treated primary aldosteronism: the German Conn's registry. Hypertension (2012) 1.04
Induction of ketosis in rats fed low-carbohydrate, high-fat diets depends on the relative abundance of dietary fat and protein. Am J Physiol Endocrinol Metab (2010) 1.04
The GOAT-ghrelin system is not essential for hypoglycemia prevention during prolonged calorie restriction. PLoS One (2012) 1.01
Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab (2007) 1.00
Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy. J Clin Endocrinol Metab (2012) 0.99
Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology. J Clin Endocrinol Metab (2014) 0.97
Short-term exposure to low-carbohydrate, high-fat diets induces low bone mineral density and reduces bone formation in rats. J Bone Miner Res (2010) 0.96
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial. J Clin Endocrinol Metab (2015) 0.93
Fasting levels of ghrelin covary with the brain response to food pictures. Addict Biol (2012) 0.92
Harmonization of growth hormone measurements with different immunoassays by data adjustment. Clin Chem Lab Med (2011) 0.92
(Still) longing for food: insulin reactivity modulates response to food pictures. Hum Brain Mapp (2012) 0.92
Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism. J Clin Endocrinol Metab (2014) 0.92
Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD). J Clin Endocrinol Metab (2011) 0.91
Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency. Eur J Endocrinol (2008) 0.90
Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. Arch Gynecol Obstet (2006) 0.90
The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms. Nat Commun (2013) 0.90
Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation. J Immunol Methods (2006) 0.90
Altered psychobiological responsiveness in women with irritable bowel syndrome. Psychosom Med (2012) 0.90
Mental health in the aged: prevalence, covariates and related neuroendocrine, cardiovascular and inflammatory factors of successful aging. BMC Med Res Methodol (2010) 0.88
An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses. Psychoneuroendocrinology (2011) 0.88
Ghrelin drives GH secretion during fasting in man. Eur J Endocrinol (2002) 0.88
Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab (2010) 0.87
Lack of dietary carbohydrates induces hepatic growth hormone (GH) resistance in rats. Endocrinology (2011) 0.86
Age- and sex-specific reference intervals across life span for insulin-like growth factor binding protein 3 (IGFBP-3) and the IGF-I to IGFBP-3 ratio measured by new automated chemiluminescence assays. J Clin Endocrinol Metab (2014) 0.86
CT mapping of the vertebral level of right adrenal vein. Diagn Interv Radiol (2015) 0.86
Ghrelin stimulation of growth hormone isoforms: parallel secretion of total and 20-kDa growth hormone and relation to insulin sensitivity in healthy humans. J Clin Endocrinol Metab (2012) 0.85
Association of plasma aldosterone with the metabolic syndrome in two German populations. Eur J Endocrinol (2011) 0.85
Serum IGF-I is not a reliable pharmacodynamic marker of exogenous growth hormone activity in mice. Endocrinology (2011) 0.84
Low-carbohydrate high-fat diets: regulation of energy balance and body weight regain in rats. Obesity (Silver Spring) (2008) 0.83
Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism. Rev Endocr Metab Disord (2011) 0.83
Low-dose ghrelin infusion--evidence against a hormonal role in food intake. Regul Pept (2011) 0.83
Short stature caused by a biologically inactive mutant growth hormone (GH-C53S). J Clin Endocrinol Metab (2005) 0.83
[Diagnosis of primary hyperaldosteronism]. Med Klin (Munich) (2007) 0.83
A high aldosterone to renin ratio is associated with high serum parathyroid hormone concentrations in the general population. J Clin Endocrinol Metab (2013) 0.83
A pegylated growth hormone receptor antagonist, pegvisomant, does not enter the brain in humans. J Clin Endocrinol Metab (2010) 0.82
The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects. Psychopharmacology (Berl) (2002) 0.82
Predicting metabolisable energy in commercial rat diets: physiological fuel values may be misleading. Br J Nutr (2010) 0.82
Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration. Eur J Endocrinol (2007) 0.82
Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. Eur J Endocrinol (2011) 0.82
Growth hormone and insulin-like growth factor I insensitivity of fibroblasts isolated from a patient with an I{kappa}B{alpha} mutation. J Clin Endocrinol Metab (2010) 0.82
Low-carbohydrate high-fat diets in combination with daily exercise in rats: effects on body weight regulation, body composition and exercise capacity. Physiol Behav (2012) 0.82
Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects. Psychoneuroendocrinology (2004) 0.82
Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients. Eur Heart J (2012) 0.81
Mechanisms of adrenal gland growth: signal integration by extracellular signal regulated kinases1/2. J Mol Endocrinol (2008) 0.81
Evaluation of a salivary based combined dexamethasone/CRH test in patients with major depression. Psychoneuroendocrinology (2002) 0.81
Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. J Clin Endocrinol Metab (2013) 0.81
Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays. J Hypertens (2015) 0.81
Quantification of the soluble leptin receptor in human blood by ligand-mediated immunofunctional assay. J Clin Endocrinol Metab (2002) 0.80
Failure of temozolomide and conventional doses of pegvisomant to attain biochemical control in a severe case of acromegaly. Pituitary (2012) 0.80
Isoenergetic feeding of low carbohydrate-high fat diets does not increase brown adipose tissue thermogenic capacity in rats. PLoS One (2012) 0.80
Carbohydrate content of post-operative diet influences the effect of vertical sleeve gastrectomy on body weight reduction in obese rats. Obes Surg (2012) 0.80
A microsphere-based duplex competitive immunoassay for the simultaneous measurements of aldosterone and testosterone in small sample volumes: validation in human and mouse plasma. Steroids (2010) 0.80
Blunted diurnal cortisol pattern is associated with frailty: a cross-sectional study of 745 participants aged 65 to 90 years. J Clin Endocrinol Metab (2014) 0.80
Short term regulation of aldosterone secretion after stimulation and suppression experiments in mice. J Mol Endocrinol (2009) 0.80
Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment. Pituitary (2007) 0.79
Quantification of growth hormone in serum by isotope dilution mass spectrometry. Anal Biochem (2010) 0.79
Role of placental growth hormone in the alteration of maternal arterial resistance in pregnancy. J Reprod Med (2007) 0.79
Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice. Exp Biol Med (Maywood) (2009) 0.79
A guide for measurement of circulating metabolic hormones in rodents: Pitfalls during the pre-analytical phase. Mol Metab (2012) 0.79
Automated 22-kD growth hormone-specific assay without interference from Pegvisomant. Clin Chem (2012) 0.78
Phenotype selection reveals coevolution of muscle glycogen and protein and PTEN as a gate keeper for the accretion of muscle mass in adult female mice. PLoS One (2012) 0.78
Increased acylated plasma ghrelin, but improved lipid profiles 24-h after consumption of carob pulp preparation rich in dietary fibre and polyphenols. Br J Nutr (2007) 0.78
Nicotine administration in healthy non-smokers reduces appetite but does not alter plasma ghrelin. Hum Psychopharmacol (2014) 0.78
Lifelong obesity in a polygenic mouse model prevents age- and diet-induced glucose intolerance- obesity is no road to late-onset diabetes in mice. PLoS One (2013) 0.78
The diagnosis of partial growth hormone deficiency in adults with a putative insult to the hypothalamo-pituitary axis. J Clin Endocrinol Metab (2007) 0.78
Early infant growth is associated with the risk of islet autoimmunity in genetically susceptible children. Pediatr Diabetes (2014) 0.78
Genome-wide meta-analyses of plasma renin activity and concentration reveal association with the kininogen 1 and prekallikrein genes. Circ Cardiovasc Genet (2014) 0.78
Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone. J Psychiatr Res (2012) 0.77
How robust are laboratory measures of growth hormone status? Horm Res (2005) 0.77
Endocrinological effects of mirtazapine in healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry (2002) 0.77